Patents Assigned to KAKEN PHARMACEUITICAL CO., LTD.
  • Preventive or Therapeutic Agent for Chronic Inflammatory Lung Disease
    Publication number: 20080249144
    Abstract: Not only acute or chronic interstitial pneumonia and plumonary fibrosis but also chronic obstructive plumonary diseases, such as plumonary emphysema and chronic bronchitis, can be effectively prevented or treated by inhalation administration to the lung tissue of 2-{N-[4-(4-chlorobenzenesulfonylamino)butyl]-N-{3-[(4-isopropyl 2-thiazolyl)methoxy]benzyl}}-sulfamoylbenzoic acid or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: July 21, 2005
    Publication date: October 9, 2008
    Applicant: KAKEN PHARMACEUITICAL CO., LTD.
    Inventors: Toshiaki Okuda, Shigeo Kurokawa, Takahiko Murata, Masahiro Amakawa, Tsutomu Nakamura